ClinVar Miner

Submissions for variant NM_001276345.2(TNNT2):c.852-2A>C

dbSNP: rs111692981
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000484808 SCV000566974 pathogenic not provided 2015-06-19 criteria provided, single submitter clinical testing Although the c.822-2 A>C substitution has not been reported as a pathogenic variant or as a benignpolymorphism to our knowledge, this variant destroys the canonical splice acceptor site in intron 15 and ispredicted to cause abnormal gene splicing. The variant is predicted to lead to either an abnormal messagethat is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message isused for protein translation. Other splice site variants in the TNNT2 gene have been reported in HGMDin association with cardiomyopathy (Stenson P et al., 2014). In summary, c.822-2 A>C in the TNNT2 gene is interpreted as a pathogenic variant.
Ambry Genetics RCV000618372 SCV000740250 uncertain significance Cardiovascular phenotype 2017-11-28 criteria provided, single submitter clinical testing The c.822-2A>C intronic variant results from an A to C substitution two nucleotides upstream from coding exon 16 in the TNNT2 gene. This nucleotide position is highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native splice acceptor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. However, loss of function of TNNT2 has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV002526539 SCV003235513 uncertain significance Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 2022-09-14 criteria provided, single submitter clinical testing This variant has not been reported in the literature in individuals affected with TNNT2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 15 of the TNNT2 gene. It does not directly change the encoded amino acid sequence of the TNNT2 protein. It affects a nucleotide within the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 419277).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.